Author:
Brandi G,Pantaleo M A,Galli C,Falcone A,Antonuzzo A,Mordenti P,Di Marco M C,Biasco G
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Andre' T, Bensmaine MA, Louvet C, Francois E, Lucas V, Desseigne F, Beerblock K, Bouche O, Carola E, Merrouche Y, Dupont-Andre G, De Gramont A (1999) Multicentric phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol 17: 3560–3568
2. Bertheault-Cvitkovic F, Jami A, Ithzaki M, Deprès Brummer P, Brienza R, Adam R, Kunstlinger F, Bismuth H, Misset JL, Levi F (1996) Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer. J Clin Oncol 14: 2950–2958
3. Caussanel JP, Levi F, Brienza S, Misset JL, Itazhaki M, Adam R, Milano G, Hecquet B, Mathè Get (1990) Phase II trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate. J Natl Cancer Inst 82: 1046–1050
4. Cleare MJ, Hughes EG, Jacob B, Pepys B (1976) Immediate (type I) allergic responses to platinum compounds. Clin Allergy 6: 183–195
5. De Gramont A, Boni C, Navarro M, Tarbenero J, Hickish T, Topham C, Bonetti A, Clingan P, Dvidson N, Mounedji-Boudiaf L, André T (2002) Oxaliplatin/5-FU/LV in adjuvant colon cancer: safety results of the international randomized MOSAIC Trial. Abstract 525, ASCO 2002
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献